Yuanyuan X. Zeng

Suzhou, 215000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Targeting KIF11 degradation: Oxypeucedanin inhibits lung adenocarcinoma progression by disrupting the MCM2-CDK1 signaling pathway.

Targeting KIF11 degradation: Oxypeucedanin inhibits lung adenocarcinoma progression by disrupting the MCM2-CDK1 signaling pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 10, 2026

Outer membrane vesicles of carbapenem-resistant Acinetobacter baumannii derive an enhanced inflammatory response.

Outer membrane vesicles of carbapenem-resistant Acinetobacter baumannii derive an enhanced inflammatory response.

Journal: Microbiology spectrum

Published: January 29, 2026

Rosuvastatin Ameliorates the Initiation and Progression of Lung Adenocarcinoma via Facilitating PLK1 Inhibition.

Rosuvastatin Ameliorates the Initiation and Progression of Lung Adenocarcinoma via Facilitating PLK1 Inhibition.

Journal: Frontiers in bioscience (Landmark edition)

Published: December 16, 2025

Correction: Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-induced epithelialmesenchymal transition and metastasis by controlling TIF1 in non-small cell lung cancer.

Correction: Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-induced epithelialmesenchymal transition and metastasis by controlling TIF1 in non-small cell lung cancer.

Journal: Molecular cancer

Published: November 18, 2025

Unveiling poliumoside: A herbal-derived FAK kinase inhibitor with anti-proliferative and anti-metastatic efficacy.

Unveiling poliumoside: A herbal-derived FAK kinase inhibitor with anti-proliferative and anti-metastatic efficacy.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 06, 2025

Complexes Formed by the K63-Specific Deubiquitinating Enzyme BRCC36: New Promising Therapeutic Targets in Human Disease.

Complexes Formed by the K63-Specific Deubiquitinating Enzyme BRCC36: New Promising Therapeutic Targets in Human Disease.

Journal: Biomolecules

Published: October 25, 2025

SERBP1 is required for efficient HR repair and cisplatin chemoresistance in lung adenocarcinoma.

SERBP1 is required for efficient HR repair and cisplatin chemoresistance in lung adenocarcinoma.

Journal: Cell death discovery

Published: October 09, 2025

Pathogen-induced mitochondrial dysfunction: mechanistic insights, immune crosstalk, and therapeutic opportunities.

Pathogen-induced mitochondrial dysfunction: mechanistic insights, immune crosstalk, and therapeutic opportunities.

Journal: Frontiers in cellular and infection microbiology

Published: September 28, 2025

SHMT2 inhibition triggers mitochondrial apoptosis to suppress lung adenocarcinoma progression.

SHMT2 inhibition triggers mitochondrial apoptosis to suppress lung adenocarcinoma progression.

Journal: Journal of translational medicine

Published: August 29, 2025

Integrated analysis of the oncogenic value of CPNE3 in non-small cell lung cancer.

Integrated analysis of the oncogenic value of CPNE3 in non-small cell lung cancer.

Journal: Discover oncology

Published: June 16, 2025

IFIT3 stabilizes STING via USP18 to drive M1 macrophage polarization and early inflammation in acute lung injury.

IFIT3 stabilizes STING via USP18 to drive M1 macrophage polarization and early inflammation in acute lung injury.

Journal: Cellular and molecular life sciences : CMLS

Published: May 21, 2025

N6-methyladenosine-mediated upregulation of PAICS promotes lung-adenocarcinoma metastasis via the integrin-FAK signaling.

N6-methyladenosine-mediated upregulation of PAICS promotes lung-adenocarcinoma metastasis via the integrin-FAK signaling.

Journal: Oncogene

Published: April 15, 2025

Showing 1-12 of 81

Last Updated: 09/26/2026